Asia-Pacific Bioinformatics Market is expected to grow at a CAGR of 14.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Asia-Pacific bioinformatics is a highly fragmented market, which includes number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
Major players operating in the market are introducing a wide range of products. This helps them maximize their sales with enhanced product portfolio.
Quest Diagnostics Incorporated is the dominating player in Asia-Pacific bioinformatics market. Other key players existing in the market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Innoplexus, Eurofins Scientific, WATERS, SOPHiA GENETICS, Partek, Incorporated, DNASTAR, DASSAULT SYSTEMES, DNANEXUS, INC., Syntekabio,, Inc., Quest Diagnostics Incorporated, Accely Group, and others.
Quest Diagnostics Incorporated was established in the year 1999 and its headquarter is located in the U.S. The Company is focused on producing advanced diagnostic services and information across the world. DIS Business and DS Business are the major business segments of the company. In addition, the company has a wide range of product categories including patients, physicians & hospitals, companies & organization, in which physicians &hospitals is a market focused category.
The company offers services in all over North America, Europe, Asia-Pacific, and the Middle East and Africa regions.
The company was established in 1981 and it’s headquarter is located in France. It offers solutions on life science, healthcare, manufacturing industries, and other infrastructure facilities across the world. The major business segments of the company are transportation & mobility, aerospace & defense, marine & offshore, industrial equipment, high-tech, home & lifestyle, consumer packaged goods & retail, life sciences, energy & materials, construction, cities & territories, construction, and cities & territories, from which life sciences is a market focused segment. In addition, the company offers a wide range of product categories including CATIA, SOLIDWORKS, ENOVIA, DELMIA, SIMULIA, GEOVIA, 3DVIA, BIOVIA, NETVIBES, 3DEXCITE, and Centric PLM, MEDIDATA under which BIOVIA is a market focused category.
The company has presence across the globe in North America, Europe, Asia-Pacific, and Africa.
The company was founded in 2013 with its headquarter based in New Zealand. The company is engaged in developing bioinformatics solutions and interpretations for sequencing of data. Geneious Prime and Geneious Biologics are the product categories offered by the company, both of which are market focused.
Asia-Pacific Bioinformatics Market – Industry Trends and Forecast to 2028